Ivanna V. Bihun

Secreted factors from equine mesenchymal stromal cells diminish the effects of TGF‐β1 on equine dermal fibroblasts and alter the phenotype of dermal fibroblasts isolated from cutaneous fibroproliferative wounds

R. Harman, G. R. Van de Walle, Ivanna V. Bihun, 2017, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

Nicholas D. Camarda, S. Carter, A. Iafrate, 2020, Nature Genetics.

The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases

A. Giobbie-Hurder, S. Carter, H. Wakimoto, 2019, Clinical Cancer Research.

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.

A. Giobbie-Hurder, S. Carter, D. Cahill, 2019, Blood advances.

A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

D. Cahill, W. Curry, P. Brastianos, 2018, Neurosurgery.

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases

Brian L. Shaw, S. Carter, S. Prakadan, 2021, Nature Communications.

Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas

Sarah E. Johnstone, D. Cahill, M. Frosch, 2019, Journal of Neurological Surgery Part B: Skull Base.

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

Julie M. Batten, S. Carter, A. Iafrate, 2018, Acta Neuropathologica.

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

Nicholas D. Camarda, S. Carter, A. Iafrate, 2020, Nature Genetics.

Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases

Brian L. Shaw, S. Carter, S. Prakadan, 2021, Nature Communications.

Phase II study of pembrolizumab in leptomeningeal carcinomatosis.

A. Giobbie-Hurder, S. Carter, S. Prakadan, 2018 .